APA (7th ed.) Citation

C, F., F, M., V, M., M, G., A, S., A, M., & N, M. (2018). What is known about deferasirox chelation therapy in pediatric HSCT recipients: Two case reports of metabolic acidosis. Dove Medical Press.

Chicago Style (17th ed.) Citation

C, Fucile, Mattioli F, Marini V, Gregori M, Sonzogni A, Martelli A, and Maximova N. What Is Known About Deferasirox Chelation Therapy in Pediatric HSCT Recipients: Two Case Reports of Metabolic Acidosis. Dove Medical Press, 2018.

MLA (9th ed.) Citation

C, Fucile, et al. What Is Known About Deferasirox Chelation Therapy in Pediatric HSCT Recipients: Two Case Reports of Metabolic Acidosis. Dove Medical Press, 2018.